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According to the International Olympic Committee, the abuse of anabolic androgenic steroids (AASS) 
is found in over 50% of positive doping tests. AASS abuse is not restricted to the organized sports and 
widespread use. It remains as an unsolved public-health problem. 
Lower black market price, easier access to AASS, bodybuilding clubs and internet advertising are 
factors of this increasingly misuse. There is not real data about the prevalence of AASS abuse in 
various populations or countries, because most of athletes or students, due to their prohibition or 
ethical aspects do not admit to AASS abuse. Often they are aware of the risks of their choice and yet, 
are eager to put themselves at risk without deeper consideration. The abusers use them to improve 
their physical fitness and appearance.
Present article has been collected to elucidate the risks and adverse effects of AASS and explanation of 
mechanisms of these events.
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Testosterone is the primary male sex hormone 
and is responsible for the androgenic (growth of sex 
organs and secondary male properties) and anabolic 
(nitrogen  retention   and  protein  synthesis)  effects. 
Related   substances   include   anabolic   androgenic 
steroids   (AASS)   as   well   as   prohormones, 
Androstendione   (Andro)   and 
Dehydroepiandrosterone (DHEA), which are steroids 
in the biosythesis pathway (1, 11). First, French 
physiologist Charles Edouard Brown-Sequard (1889) 
recognized the anabolic effect of a testicular extract 
of dogs and guinea pigs when given subcutaneously 
(14).   Then,   the   isolation   of   testosterone   from 
testicular   extract   in   1935   and   following   studies, 
demonstrated that this substance stimulated a strong 
positive nitrogen balance in castrated dogs and rats, 
although its rapid degradation restricted its oral or 
parentral administration. In addition, testosterone has 
a therapeutic index of 1 meaning, there is similarity 
in   the   proportion   between   the   anabolic   and 
androgenic   effects,   and   chemically   modification 
became necessary to more active substances with 
increased   anabolic   effect   and   avoid   first-pass 
metabolism,   and   better   systemic   availability. 
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Investigations   have   led   to   synthesis   of   anabolic 
steroids (10, 11).
"Anabolism" is defined as any state, in which, 
nitrogen is differentially retained in lean body mass, 
either through stimulation of protein syntheses and or 
decreased  breakdown of protein anywhere in the 
body. Since no drugs currently are "purely" anabolic, 
yet possess some androgenic property which cannot 
be totally separated from anabolic effect, and all 
possess at least some androgenic activity, therefore, it 
is   more   appropriate   to   use   the   term   anabolic 
androgenic steroids (AASS) (9, 14).
Boje   (1939)   was   the   first   to   suggest   that 
exogenous testosterone administration may enhance 
the athletic performance. The first dramatic reports of 
anabolic steroid use occurred following the 1954 
world   weightlifting   championships   and   spread 
quickly through the 1960's in various Olympic sports 
(10). 
Chemical Structure
All   androgens   possess   the 
cyclopentanophenanthrene nucleus. (Fig.1)
Structures of testosterone and some of its selected 
derivatives used as anabolic are shown in Fig 2.
Testosterone   undergoes   a   series   of 
biotransformations   when   taken   orally.   Injected 
testosterone also passes rapidly in the blood and to 
the liver and is inactivated by the cythochrome P450 
isoenzyme. Addition of an alkyl group at position 17
α   results   in   orally   active   compounds.   Alkyl 
substitution prevents deactivation of the steroid by 
first-pass metabolism. This alkyl group is commonly 
a methyl group, but in drugs such as norethandrolone, 
ethylestrenol  and norbolethone an ethyl  group  is 
present. This modification is associated with hepatic 
toxicity (9, 14). A methyl group attached to C-1 can 
also   confer   oral   activity,   as   in   methenolone   or 
mesterolone, but these compounds have relatively 
weak pharmacological activity (12). Esterification of 
the   17-hydroxy   group   delays   the   biodegradation. 
Long-chain esters are longer acting agents. These 
derivatives   are   highly   androgenic   and   due   to 
unsaturated C-4, 5 double bond can be aromatized to 
estrogen (9). Substitution of hydrogen for the methyl 
group in position C-19 results in 19-nortestosterone 
(nandrolone).   Esterification   of   nandrolone   with 
cyclohexylpropionate,   decanoate,   laurate   and 
phenylpropionate yields products with more stabil 
and anabolic properties (9, 13). Oxandrolone has a 
lacton   ring  and  an   oxygen   molecule  at   the  C-2 
position,   whereas   oxymetholone   contains   a 
hydroxymethyl group at same position. At present, 
metandienone (Dianabol)
R that has been banned since 
1987 in America and Western Europe, is a frequently 
used drug among bodybuilders. Stanozolol was the 
first derivative with a heterocyclic pyrazole ring and 
is banned in Germany, but approved for the oral 
application in USA (9). Comparison of anabolic-
androgenic   ratio   for   selected   AASS  is   shown   in 
Table-1 (12, 14).
Fig. 1. Basic structure of steroid hormones and the possibilities of chemical derivatization
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Fig. 2. Structures of testosterone and synthetic derivatives
Table 1. Anabolic:Androgenic Ration for Selected Anabolic Drugs
Steroid  Route  Reference steroid  Activity  Index value 
      Myotrophic  Androgenic   
Chloromethyl T p.o. 17 -MeT 0.5 0.10–0.15 3–5
Methandienone p.o. 17 -MeT 0.60 0.20 3
Methenolone acetate p.o. 17 -MeT 0.86 0.12 7
Nandrolone decanoate par. T propionate 3.29–4.92 0.41–0.31 12.1–10.6
Norbolethone
a  par. T propionate 3.44 0.15–0.17 20
Norethandrolone par. T propionate 0.77–1.0 0.06–0.38 2–16
Oxandrolone
b  par. 17 -MeT 3.22 0.24 13
Oxymesterone p.o. 17 -MeT 1.34 0.42–0.61 2.2–3.2
Oxymetholone p.o. 17 -MeT 3.20 0.45 7.1
Stanozolol p.o. 17 -MeT 2.0–3.7 0.33–0.52 6–10.6
T p.o. 17 -MeT 0.36 0.28–0.50 0.7–1.3
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Mechanism of action and pharmalogic effects
AASS  have relatively small molecules and can 
passively diffuse into cells of various tissues. No 
tissues   are   devoid   of   androgen   receptors.   These 
receptors belong to the family of nuclear receptor 
superfamily   and   different   AASS  bind   to   these 
receptors   with   different   affinities,   although   all 
receptors distributed throughout the body possess the 
same binding affinity for a particular steroid (12). 
After binding to the receptor in target tissue and 
formation   of   hormone-receptor   complex,   AASS 
translocate to binding sites on chromatin, promoting 
gene   transcription   and   subsequent   synthesis   of 
mRNA. Due to the environmental conditions such as 
the presence of different enzymes (e.g 5 α -reductase 
and aromatase) and presence of receptors,  AASS 
effects   vary   in   different   tissues.   Enzyme   5 α -
reductase   seems   to   play   an   important   role   in 
converting   AASS  into   female   sex   hormones   (7). 
Young adolescents are more suspectible to androgen 
action   of   AASS,   because   they   possess   a   higher 
number of cytosol androgen receptor (11). Recent 
studies   also   have   shown   that   the   expression   of 
andogen receptors can be upregulated by exposure to 
supraphysiologic doses of AASS (12, 14). 
Supraphysiologic doses of AASS can induce gain 
in   muscle   size   and   strength,   even   without 
concomitant exercise. At these doses AASS interact 
with   various   receptors,   including   progesterone, 
estrogen and mineralo- and glucocorticoid receptors. 
They   mediate   their   anabolic   action   through 
competitive antagonistic action to the glucocorticoid 
receptors   by   preveriting   glucocorticoid's   catabolic 
effect (7, 11, 12, 14). After administration of AASS, 
the circulating concentrations of thyroxin, cortisol, 
sex   hormone,   growth   hormone   and   D-vitamin-
binding globulin are decreased.  It  has also been 
suggested that AASS  exert several complementary 
anabolic   effects   through   pathways   such   as   a 
psychoactive   effect   on   the   brain,   glucocorticoid 
antagonism, stimulation of growth hormone (GH) 
and insulin-like growth factor 1 (IGF-1) production 
(12, 19).
More   than   100   synthetic   derivatives   of 
testosterone have been developed. They are well 
absorbed from the gastrointestinal tract, then undergo 
biotransformation   during   the   hepatic   first-pass 
metabolism and partly exerted via bile to the faces. 
Since they are potential targets for aromatization and 
reduction, have various biological properties (11). 
Their   clinical   indications   include   treating   of 
hypogonadism,   impotence,   delayed   puberty   (in 
Turner's   syndrome,   etc…),   catabolic   disorders   as 
muscle   wasting   and   cachexia   caused   by   various 
cancers and HIV infection, diaphragm atrophy due to 
catabolic-proteolysis   effect   of   glucocorticoids   in 
chronic   obstractive   pulmonary   disease   (COPD), 
osteoporosis,   types   of   anaemia   (such   as   aplastic 
anaemia,   fanconi   anaemia,   myelofibrosis,   etc), 
endometriosis and fibrocystic breast disease, alcohol 
hepatitis, wound and burn healing (by increasing 
collagen   synthesis   and   the   activity   of   dermal 
fibroblasts), renal failure (specially in patients on 
hemodialysis) (4, 9, 11, 12, 13). In general, ergogenic 
effects of these agents are resulted from an increase 
in muscle size and strength and reduced  muscle 
damage, increase in protein synthesis, increase in 
lipolysis   and   body  fat   percent,   increase   in   bone 
mineral   density,   increase   in   erythropoiesis, 
hemoglobin and hematocrit and increase in glycogen 
storage (9, 10).
AASS abuse 
AASS  are   controlled   substances   in   several 
countries,   including   Australia,   Argentina,   Brazil, 
Canada, the United Kingdom and the United states. 
Even so, they are readily available via the internet, 
black market and sport clubs. In the United states, the 
majority of substances come from Mexico, Russia, 
Romania   and   Greece,   whereas   in   the   European 
market come from countries within the European 
Union and Russia and sometimes from Thailand, 
Turkey, Egypt, India and Pakistan (10, 12). 
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As mentioned before, their beneficial effects on 
all sports demanding peak physical performance were 
noticed in the early 1950. It is impossible to estimate 
the extent of AASS  use in 1950s and 1960s. The 
International Olympic Committee included AASS on 
a   list   of   prohibited   substances   in   1975   and 
testosterone   in   1982,   however   the   percentage   of 
positive doping test results in the summer Olympic 
Games   during   1976-1988   varied   between   O  and 
2.9%.   Due   to   the   secretive   nature   of   doping, 
estimating the extent of doping abuse in modern 
organized   sports   is   difficult,   but   it   is   clear   that 
throughout the world, the majority of positive doping 
test results are due to AASS abuse (10, 11).
The  motive for  AASS  abuse  is  derived  from 
performance enhancing and self-image improvement. 
Competitive athletes as well as recreational fitness 
athletes are aware of the adverse effects of them and 
consume   antiestrogens   and   HCG   to   avoid   these 
effects. Other self-administrated drugs among AASS 
abusers are GH, IGF-1, dopamine receptor agonists 
(bromocriptin), adrenergic   β 2-agonists, stimulants 
(ephedrine, amphetamine …), thyroxin, finasteride, 
diuretics,   insulin,   oral   antidiabetic   drugs, 
aminogluthetimine, antiacne drugs and NSAIDS (11, 
19). Multipharmacy (Polypharmacy) that has been 
reported in more than 95% of 500 abusers in a recent 
study, could potentiate the severity of adverse effects 
and may causes difficulty in the separation of side 
effects (10, 19).
Most of epidemiologic studies of AASS  abuse 
have been made in adolescents and young adults, 
who are considered the most likely abusers. The non-
medical use of AASS had increased by 50% of male 
adolescents   between   1991and   1999   in   America. 
Results of several reports suggest a 3-12% prevalence 
of  AASS  use  in   Western   world   (11),   and   other 
surveys  report that 2/7-2/9% of young American 
adults have taken AASS  at least once in their life. 
Abuse percentage for bodybuilding clubs is estimated 
15-30% (19).
According   to   the   results   from   the   2003 
monitoring study, 3/5% of high school seniors (males 
and   females)   have   history   of  AASS  use   with   a 
dramatic increase in females over the past few years 
(1). Abuse prevalence among females is more than 
1% (9). Reported data in American high-school girls 
has been more than 7% in 2004 and it became a topic 
discussed during the 2005 congressional hearing in 
sports (5). NIDA (National Institute of Drug Abuse) 
report in 2007 was 2.3% of boys versus 0.6% for girls 
(17). There are contrary reports about the influence of 
public-health advertising, counseling and educational 
programs on reduction of the AASS  abuse. Several 
reports indicate that drug abuse can be decreased by 
health promotion activities, such as group discussion 
and   health   and   nutrition   knowledge   with   early 
preventive efforts (18, 23), whereas in study on 26 
subjects in Finland, despite that they followed for one 
year and received adequate information concerning 
their health status (all had cardiovascular problem), 
none of them discontinued substance abuse after the 
study (11). 
Most users take AASS  in a "cycling" pattern, 
meaning that athletes will use the drugs for several 
weeks   or   months   interrupted   by   shorter   resting 
periods.   In   addition,   users   also   use   agents   in   a 
"stacking" regimen in which they consume several 
different   drugs   simultaneously   to   increase   the 
potency of each drug. They will use both oral and 
parenteral compounds. Often the athletes use drugs in 
a pyramid (step-up) pattern in which dosages are 
steadily increased over several weeks. Toward the 
end of the cycle the athlete will "step-down" to 
reduce the likelihood of negative side effects. At this 
point, some athletes will discontinue drug use or 
perhaps initiate another cycle of different drugs. 
In staking way may be used up to 40 times the 
recommended therapeutic dosage (10, 15, 17).
Adverse effects 
In clinical dosages, AASS are well tolerated and 
their adverse effects are reversible. The severity and 
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frequency of adverse effects are variable and are 
related to factors such as type, dosage, use duration, 
individual response and sensitivity and gender. A 
survey of 500 abusers shows that nearly 100% of 
AASS  users reported  subjective side effects (19). 
AASS- induced adverse effects are mainly based on 
case reports and studies with controlled, a proper 
study design and matching control group have not 
been published. Since they have effects on several 
organ systems, a myriad of side effects can be found. 
In general the orally forms of AASS  and 17 α -
alkylated compounds have more side effects (11, 15).
Polypharmacy is an important factor. The major 
side effects associated with AASS use are discussed. 
Cardiovascular system
In   general,   cardiovascular   changes   have   been 
related to four mechanisms:
1- Atherogenic lipoprotein changes
2- Thrombogenic effects on clothing factors and 
platelets
3- Vasospasm effects on the vascular nitric oxide 
system 
4- Direct myocardial toxicity (3).
Physical activity has beneficial effects on heart 
size, shape and function. Left ventricle (LV) mass is 
45% greater in competitive athletes than sedentary 
controls, however, diastolic function in athletes' heart 
is generally normal, in contrast to pathological LV 
hypertrophy that is associated  with impaired  LV 
filling. Endurance sports develop larger LV cavity 
dimensions without a significant increase in wall 
thickness (eccentric hypertrophy) (11). Although the 
previous data have shown that LV remodeling is 
reversible after discontinuation of AASS use, present 
studies   by   echocardiography   suggest   the   slight 
concentric   LV   hypertrophy   and   cardiovascular 
changes several years after discontinuation of AASS 
(22).
LV hypertrophy is an independent risk factor for 
cardiovascular morbidity and mortality and has been 
linked to atrial fibrillation, ventricular arrhythmia and 
sudden cardiac death. AASS-induced LV hypertrophy 
changes diastolic function and is associated with 
concentric remodeling of LV hypertrophy. There are 
reports   about   occurrence   of   cardiac   infarction 
development   of   ischemia   and   cardiomyopathy   in 
AASS  abusing bodybuilders (9, 10, 11). Although 
some of researchers have observed hazardous and 
remodeling effects on heart structure and function in 
animal studies, they have not attributed such effects 
in human studies (7).
The lengthening of QT interval among endurance 
athletes with AASS abuse history has been attributed 
to the increased automaticity. Lengthening of QT 
interval can generate dysrythmia and increase the risk 
of ventricular and artrial fibrillation (3, 11).
Results of study in rats with cardiac ischemia 
suggest that nandrolone increases the risk of fatal 
arrhythmia and this event is dose-dependent (20).
Several pathophysiological and histopathological 
mechanism  have  been   purposed   to  explain   these 
cardiac events that include:
Ischemic events as a result of the disturbance in 
mitochondria,   increased   vascular   response   to 
norepinephrine and induction of cell adhesion (3), 
depressed contractile activity, increased lysosomal 
fragility (11), hypertension due to the inhibition of 
monoamine oxidase (MAO) in combination with the 
increased renal recovery of ions such as sodium and 
subsequent fluid retention (13),  increased  cardiac 
collagen content associated with activation of the 
local renin-angiotensin system (21) and even possible 
relation with simultaneous use of other agents such as 
GH (10).
AASS abuse cause harmful changes in lipoprotein 
profile with increased LDL level (by 40-50%) and 
decreased   HDL   level   (by  40-70%).   Triglycerides 
levels are decreased by the exogenous administration. 
Consistent increase in LDL levels might result in the 
atherosclerosis thrombus formation, coronary artery 
vasosopasm and enhanced coagulation enzyme. The 
JOURNAL OF STRESS PHYSIOLOGY & BIOCHEMISTRY Vol. 5 No. 3 2009
28ABUSE OF ANABOLIC ANDROGENIC STEROIDS  
reduction in HDL is due to a stimulation of hepatic 
triglyceride lipase (in males) and lipoprotein lipase 
(in females that regulate serum lipids) by 17 α -
alkylated compounds mainly (3, 9, 15). There is a 
report that AASS have a beneficial effect on serum Lp 
(a) levels, although the HDL/LDL-ratio is reduced. 
The alterations in the lipoprotein profile reverse after 
discontinuation of AASS (11).
Hepatic effects
Structure and function of liver as primary site of 
AASS  clearance may be altered. These alterations 
include   intrahepatic   cholestasis,   jaundice, 
hyperplasiua,   benign   (adenoma's)   and   malign 
(hepatocellular   carcinoma)   tumors   and   peliosis 
hepatis.   Peliosis   hepatis   is   a   hemorrhagic   cystic 
degeneration of the liver, which may lead to fibrosis 
and portal hypertension. Rupture of a cyst may lead 
to fatal bleeding (9, 15). It seems that hepatic cancers 
generally   occur   with   higher   frequency   in   males 
compared to females (10). 
Many opinions have been raised based on case 
reports   and   conclusions   may   be   contradictory. 
Although there are hazards particularly with oral 
products (17 α -alkylated) in prolong use (9, 10).
Some researches have reported the increase in 
plasma activity of liver enzymes such as aspartate 
aminotransferase   (AST),   alanine   aminotransferase 
(ALT),   alkalin   phosphatase   (AP),   lactate 
dehydrogease (LDH), whereas findings of gamma 
glutamyl   transpeptidase   (GGT)   have   been 
controversy. Therefore, the pre-abuse condition of the 
liver may be an important factor (10, 13, 15). AASS 
use also results in suppression of clotting factors II, 
V, VII and X as well as an increase in prothrombin 
time. In general, drug cessation results in complete 
recovery (13).
Reproductive and endocrine effects
The effects of AASS  on the male reproductive 
system include reductions in the levels of endogenous 
testosterone, gonadotrophic hormones, sex hormone-
binding globulin, reductions in testicle size, sperm 
count and sperm motility, increase in abnormal sperm 
cells, decreased fertility and changes in libido. After 
discontinuation of AASS use the changes in fertility 
usually reverse within some months, however, the 
situation of hypogonadism may lasts for long periods 
(1, 10, 15). 
Gynecomastia results from increased levels of 
circulating estrogens which are formed in males by 
peripheral aromatization and conversion of AASS. 
Increased levels of estrogens stimulate breast growth 
in males. In general, gynecomastia is irreversible and 
may require to be treated medically or surgically (13, 
15). 
Also, the incidence of benign prostate hyperplasia 
(BPH) or its worsening is probable. In addition, the 
use of AASS in patients with underlying carcinoma of 
the prostate is absolutely contraindicated due to the 
potentiality for hormone-sensitive tumor growth (13). 
AASS through increasing in circulating androgens 
will inhibit the production and release of LH and 
FSH, resulting in a decline in serum levels of LH, 
FSH, estrogens and progesterone. Thus AASS abuse 
in females can induce hirsutism, deepening of the 
voice, clitoris hypertrophy, breast atrophy, menstrual 
disorders or amenorrhea, and male pattern baldness 
(9, 15).
Other effects such as acne as well as hypertrophy 
of sebaceous glands, oily hair and skin and alopecia 
are frequently reported in both males and females 
(15). 
AASS have also been shown to alter fasting blood 
sugar   levels   and   decrease   glucose   tolerance   and 
induce   hyperinsulinemia   due   to   probably   hepatic 
effect   or   changes   in   insulin   receptors   that   are 
reversible alterations (1, 13).
Thyroxin-binding   globulin   (TBG)   and   thyroid 
stimulating hormone (TSH) may be lowered whereas 
total T4 levels are lowered and free T4 levels remain 
normal (13, 15).
Psychological and behavioral effects
Historically low doses of AASS have been used to 
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treat   depression   and   melancholia   either   as 
monotherapy or as adjuncts to standard treatment, but 
misuse of these agents has added a new term to the 
drug lexicon, "roids rage".  Comparison of AASS 
abuser athletes with non-abusers have shown that 
their abuse is associated with higher incidence and 
prevalence   of   affective   disorders   and   psychiatric 
symptoms such as manic-like presentations (defined 
by irritability,  aggressiveness,  euphoria, grandiose 
beliefs,   hyperactivity   and   violence   or   dangerous 
behavior), acute psychosis, exacerbation of tics and 
depression,   acute   confusional-delirious   states   (6), 
hallucinations,   paranoia,   anxiety   and   sleeping 
disorders (15).
The severity  of psychiatric   adverse  effects  is 
dose-related. It has been demonstrated that 23% of 
users of medium dose (between 300-1000 mg/week 
of   any   AAS)   and   high   dose   (more   than   1000 
mg/week of any AAS) met the DSM-III-R criteria for 
a major mood syndrome (mania, hypomania, and 
major depression) and 3.4-12% developed psychotic 
symptoms. 
The   symptoms   usually   resolve   within   a   few 
weeks after discontinuation of steroid use, although 
they may persist for as long as 1 month, even if 
adequately treated with antipsychotic medication (6).
These effects must be viewed as a social-medical 
problem,   because   in   spite   of   methodological 
inadequacies   of   related   studies,   AASS-induced 
aggression and irritability (that are beneficial trait for 
competitive trainings) are clearly demonstrated with 
AASS use and there is claim of attempt murder during 
AAS-taking   phase   and   also   multipharmacy   or 
stacking   may   increase   the   severity   of   violence 
symptoms (2, 24). 
According the psychological studies, following 
factors are considered as a part of typical AASS 
abuser   personality   traits:   poor   self-esteem,   poor 
school   performance,   higher   socioeconomic   state, 
poor body image, a familial history of drug abuse, 
history of aggression and violence, etc (6).
Behavioral mechanisms of AAS-induced effects 
are not clearly proved, although hypotheses have 
been   supposed   such   as   allosteric   modulation   of 
GABAA receptor, changes of serotonin receptors and 
role of hypothalamic arginin-vasopressin system (6, 
12).
AAS addiction is considered as a psychic as well 
physical   addiction.   Withdrawal   symptoms   are 
depression, fatigue, headache, muscle and joint pain, 
decreased   sexual   drive   insomnia   and   suicidal 
thoughts and feelings, which could be named as 
"withdrawal syndrome".
As many as 23% of users reported major mood 
syndrome as a result of discontinuation of AAS. 
Androgen withdrawal is often associated with the 
desire to resume steroid consumption or "craving" 
(8, 13).
Human withdrawal mechanism may associated 
with   decreased   central   dopaminergic   activity. 
Administration of clonidine, tranquilizers, analgesics 
and antidepressant fluoxetin has been effective in 
treating of androgen withdrawal syndrome (8).
Musculoskeletal system and connective tissue 
AASS  may lead to premature epiphyseal plate 
closure   through   large   production   of  estrogens   in 
aromatization processes. There are reports about the 
risk of tendon injury, mostly in powerlifters, even the 
ligamentous ruptures may be due to the excessive 
loads.   AASS  may   cause   to   the   alteration   of 
contractility of myofibrils and collagen fibers and 
biomechanical properties of tendons (9, 10).
Study   in   rats   suggests   that   AASS  abuse   is 
associated with elevation in collagen synthesis and 
can   impair   tissue   remodeling   in   tendons   of  rats 
undergoing physical exercise by inhibition of matrix 
metalloproteinase activity (16). Rhabdomylysis, or 
acute skeletal muscle destruction may occur after use 
of   AASS  in   combination   with   weight-training 
programs (9).
Other adverse effects
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Reports of renal side effects are contradictory. 
High levels of serum urea, serum uric acid and 
hyperphosphatemia and possible nephrosclerosis with 
obstructive glomerulosclerosis  have been reported 
(9).
AASS have also been associated with suppression 
of immune function, changes of haemostatic system 
(7), occurrance of Wilms' tumor (15), infections at 
the injection site of bacterial or fungal aetiology, 
increased risk of hepatitis and AIDS as a result of 
shared   needles   and   syringes   (11),   increase   in 
hematocrit   and   hemoglobin   and   possible 
polycythemia (13), and sleep apnea. Multiple drug 
abuse to `counterbalance the side effect or to support 
the   anabolic   effects   of   AASS  is   also   a   serious 
consequence of AASS  use that may lead to worse 
conditions. (15)
Conclusion
Although  AASS  use   has   been   forbidden   in 
organized   sports   nearly   thirty   years,   their   abuse 
remains   one   of   the   important   problems   as   a 
widespread   phenomenon   in   both   athletic   and 
nonathletic populations. Due to the secretive nature 
of their abuse and for ethical reasons, estimating of 
real prevalence of AASS use and the number of users 
are difficult. The major motive for their abuse is to 
enhance physical  fitness and appearance.  Despite 
evidence of increased risks of AASS,  abusers are 
simply   maпve   regarding   the   dangers   of   these 
substances. Although most of adverse effects seem to 
be reversible, particular concern is the increased risk 
of cardiovascular and hepatic events and effects on 
reproductive,   endocrinological   and   psychological 
systems. AASS  as well other performance enhancing 
supplements are widely advertised in fitness clubs 
and related websites and are available by low price 
on black markets. Thus, fundamental guidelines must 
be   invented   with   the   means   of   counseling   and 
educational   programs   to   provide   warnings   about 
potential   dangers   of   AASS  misuse   without 
exaggerated or disregarded attitude.
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